glp-1 cgm and GIP in Type 1 Diabetes Therapy: A Time for Reappraisal? Evaluating the Efficacy and Safety

brevis CGMCC1306 ( cat ) in strain GXL94, and the transcription of this gene was elevated by 25.3-fold and 6.8, when treated with 2 mM and 3 mM H 2 O 2 at primary stationary phase, respectively

Acute hemodynamic and renal effects of glucagon-like peptide 1 analog and dipeptidyl peptidase-4 inhibitor in rats

GLP-1 medications can lead to dehydration and muscle loss, so Weight Watchers provides daily nutrition targets that prioritize protein, water, and fruits and veggies

In a real-world analysis of individuals with history of opioid use disorder and alcohol use disorder (AUD), published in Addiction last October, researchers reported that GLP-1 receptor agonists and similar drugs for diabetes and weight-related conditions were associated with a 40% lower rate of opioid overdose and 50% lower rate of alcohol intoxication in people with opioid use disorder and AUDs, respectively